Positive symptoms are additions to normal experience, such as delusions and hallucinations, while negative symptoms are reductions or losses in normal function, like flat affect and avolition. This distinction best describes why some people with schizophrenia experience extra, disruptive experiences (positive) and also struggle with diminished emotional expression and motivation (negative). The other statements mix up the categories or make incorrect generalizations: flat affect is a negative symptom, not positive; hallucinations are positive symptoms, not negative; and it's not an absolute rule that negative symptoms always come first—they can appear in the prodromal phase but are not universally preceding positive symptoms.

Relapse prevention strategies in long-term schizophrenia care focus on sustaining symptom control and everyday functioning by keeping people on effective treatment and catching relapse early. They’re the best because they address both medication management and practical supports that help people stay adherent and respond quickly when warning signs appear. Key elements include education for the patient and family about the illness and the importance of ongoing medication, practical aids to adherence (such as simpler regimens or long-acting injectable options when appropriate), regular clinical follow-up, coping and stress-management skills, screening for substance use, and a clear plan for rapid action at the first signs of worsening symptoms. By promoting steady medication use and enabling early intervention, relapse prevention lowers the risk of hospitalization and helps maintain work, relationships, and daily functioning. It’s not about replacing antipsychotics with therapy, and it’s not accurate to say these strategies aren’t important—the strongest approach combines medication with proactive, structured supports that anticipate relapse and respond quickly.

Extrapyramidal symptoms from antipsychotics are movement-related side effects that need careful, targeted tracking. The tool designed to capture these changes focuses on involuntary movements across the face, mouth, limbs, and trunk, providing a structured way to rate severity and monitor progression over time. Using it helps catch issues like tardive dyskinesia early and supports timely treatment adjustments, which is crucial for maintaining function and safety. In contrast, the Beck Depression Inventory measures mood, the Mini-Mental State Examination screens cognitive function, and the Hamilton Anxiety Rating Scale assesses anxiety. None of those are built to monitor EPS, so they aren’t suitable for this purpose.

Positive symptoms are experiences added to normal functioning, such as disturbances in thinking, speech, or behavior. Disorganized speech exemplifies this because when thinking becomes fragmented, speech can become illogical, incoherent, or derail into unrelated topics. This reflects an excess or distortion of normal thought processes. In contrast, flat affect, social withdrawal, and anhedonia are negative symptoms, representing reductions or losses in normal functions like emotional expression, social engagement, and the ability to feel pleasure. So, disorganized speech is the positive symptom among the options.